These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32443038)

  • 1. The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors.
    Fleishman N; Richardson T; Attard T
    J Pediatr Gastroenterol Nutr; 2020 Jun; 70(6):815-819. PubMed ID: 32443038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Proton Pump Inhibitor Use and Risk of Fracture in Children.
    Wang YH; Wintzell V; Ludvigsson JF; Svanström H; Pasternak B
    JAMA Pediatr; 2020 Jun; 174(6):543-551. PubMed ID: 32176276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter cohort analysis of fractures in histamine-2-receptor antagonist treated pediatric patients.
    Fleishman NR; Richardson T; Attard TM
    Curr Med Res Opin; 2022 Apr; 38(4):565-570. PubMed ID: 35112645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitors increase the incidence of bone fractures in hepatitis C patients.
    Mello M; Weideman RA; Little BB; Weideman MW; Cryer B; Brown GR
    Dig Dis Sci; 2012 Sep; 57(9):2416-22. PubMed ID: 22615013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.
    van der Hoorn MMC; Tett SE; de Vries OJ; Dobson AJ; Peeters GMEEG
    Bone; 2015 Dec; 81():675-682. PubMed ID: 26319499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study.
    Lewis JR; Barre D; Zhu K; Ivey KL; Lim EM; Hughes J; Prince RL
    J Bone Miner Res; 2014 Nov; 29(11):2489-97. PubMed ID: 24825180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis or fracture risk associated with thiazolidinedione and proton pump inhibitor co-administration in patients with type 2 diabetes mellitus.
    Ock M; Lee S; Kim H
    J Clin Pharm Ther; 2022 Jul; 47(7):1028-1035. PubMed ID: 35257383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fracture risk of young adults receiving proton-pump inhibitors and H2-receptor antagonists.
    Fedida B; Schermann H; Ankory R; Rotman D; Shichman I; Yoffe V; Shlaifer A; Luger E
    Int J Clin Pract; 2019 May; 73(5):e13339. PubMed ID: 30829427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton Pump Inhibitors, But Not H2-receptor Antagonists, Are Associated With Incident Fractures Among Kidney Transplant Recipients.
    Lyu B; Jorgenson MR; Hansen KE; Djamali A; Astor BC
    Transplantation; 2020 Dec; 104(12):2609-2615. PubMed ID: 32058466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitor use and fracture risk - effect modification by histamine H1 receptor blockade. Observational case-control study using National Prescription Data.
    Abrahamsen B; Vestergaard P
    Bone; 2013 Nov; 57(1):269-71. PubMed ID: 23973557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Do opioids, sedatives and proton-pump inhibitors increase the risk of fractures?].
    Thorsdottir G; Benedikz E; Thorgeirsdottir SA; Johannsson M
    Laeknabladid; 2017 Mai; 103(5):231-235. PubMed ID: 28489008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of proton pump inhibitors and risk of osteoporosis-related fractures.
    Targownik LE; Lix LM; Metge CJ; Prior HJ; Leung S; Leslie WD
    CMAJ; 2008 Aug; 179(4):319-26. PubMed ID: 18695179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Lin SM; Yang SH; Liang CC; Huang HK
    Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies.
    Ngamruengphong S; Leontiadis GI; Radhi S; Dentino A; Nugent K
    Am J Gastroenterol; 2011 Jul; 106(7):1209-18; quiz 1219. PubMed ID: 21483462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of the risk of osteoporotic fractures with proton pump inhibitor use and histamine-2 receptor antagonist therapy in elderly women: A nationwide population-based nested case-control study.
    Park JH; Song YM; Jung JH; Han K
    Bone; 2020 Jun; 135():115306. PubMed ID: 32126312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton Pump Inhibitor Use and Risk of Hip Fracture in Kidney Transplant Recipients.
    Lenihan CR; Sukumaran Nair S; Vangala C; Ramanathan V; Montez-Rath ME; Winkelmayer WC
    Am J Kidney Dis; 2017 May; 69(5):595-601. PubMed ID: 27866965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
    Freedberg DE; Haynes K; Denburg MR; Zemel BS; Leonard MB; Abrams JA; Yang YX
    Osteoporos Int; 2015 Oct; 26(10):2501-7. PubMed ID: 25986385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study.
    Moberg LM; Nilsson PM; Samsioe G; Borgfeldt C
    Maturitas; 2014 Aug; 78(4):310-5. PubMed ID: 24958166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fracture risk and bone mineral density reduction associated with proton pump inhibitors.
    Lau YT; Ahmed NN
    Pharmacotherapy; 2012 Jan; 32(1):67-79. PubMed ID: 22392829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between proton pump inhibitor adherence and fracture risk in the elderly.
    Ding J; Heller DA; Ahern FM; Brown TV
    Calcif Tissue Int; 2014 Jun; 94(6):597-607. PubMed ID: 24706060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.